Facebook Twitter RSS Feed

You are here

By: Candace Stuart

Guidelines designed to lower the  risk of atherosclerotic cardiovascular disease continue to spark controversy many months after their publication, primarily over two flash points: abandonment of cholesterol goals and the use of a new risk estimator. Some physicians welcome the changes and some abhor them. Others say it is time to step back and look at the bigger picture.

Third time was not the charm

The din of clanking forks and coffee cups had died down by the time Neil J. Stone, MD, took over the podium. He faced a ballroom of about 150 physicians, one third of whom minutes before had responded “hate them” to a question about their opinion of the American Heart Association/American College of Cardiology (AHA/ACC) guidelines. The guidelines were designed to help...

 - CandaceStuart
By: Candace Stuart
Lines are straight and narrow. Tacking “guide” before them in the medical world, where the best course of action may not be straightforward and contributing factors can be wide, may create confusion.
 - Paul Schaffer, PhD, TRIUMF
By: Kathy Mahdoubi
Continued shutdowns at research reactors throughout the world have created shortfalls in essential medical isotope supply for several years. 
 - Larry S. Dean, MD
By: Larry S. Dean, MD
It may seem like merely a local skirmish, but an effort by interventional cardiologists in the state of Washington to ensure coverage for drug-eluting stents serves as a roadmap for local and...
 - Cathlab Stock
By: Anna Steere
Cath lab directors must balance the availability of products such as stents with costs in an environment where demand can change quickly.
 - Decision
By: Lisa Fratt
One decision some cardiology groups may wrangle with is whether or not to launch a peripheral artery disease (PAD) program. 
 - Blue Checkmark
By: William A. Zoghbi, MD, MACC, Joseph P. Drozda, Jr., MD, FACC, Joseph M. Allen, MA and William J. Oetgen, MD, MBA
The first stages of Choosing Wisely tackled less contentious issues in its successful rollout. Now it is time to step up efforts in ambition and scope.
 - Strategic Planning Process
By: Kim Carollo
Dashboards are emerging as valuable tools for tracking performance measures and other efforts related to quality of care. 
 - AMDIS Fall Symposium
The AMDIS Fall Symposium is back! Join us in Boston on October 20th and 21st. Learn more.
 - Partners HealthCare at Home
By: Kim Carollo
Managing heart failure (HF) presents daily challenges for many patients. Reasons range from a lack of understanding about treatments to the inability to care for themselves due to symptoms.
 - Chicago
#HCLF14: Leveraging Evidence Across the Care Continuum is being held Sept. 29-30 at the Waldorf Astoria Chicago. This year's co-chairs are David W. Bates, MD and Patricia Flatley Brennan, RN, PhD....
 - TAVR and SAVR Center Volume: 2008-2012
By: Candace Stuart
The number of transcatheter aortic valve replacement (TAVR) procedures in the U.S. has been growing with FDA approval of two devices and ongoing clinical trials evaluating other new technologies.